Daiichi Sankyo (India)
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent. Daiichi Sankyo, Inc. began operating in the U.S. in 2006. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Daiichi Sankyo (India), India, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
57%
Total
Publications
311
Total Open
Publications
178
Total
Citations
3.9K
Open Access
Percentage
57%
Total
Publications
311
Total Open
Publications
178
Total
Citations
3.9K
Breakdown
Publisher Open
51%
Both
5%
Other Platform Open
2%
Closed
42%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 12%
21
Hybrid 15%
26
No Guarantees 73%
130
Other Platform Open
Domain 70%
14
Preprint 15%
3
Institution 10%
2
Other Internet 5%
1
Public 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 14 |
bioRxiv | Preprint | 3 |
University of Modena and Reggio Emilia | Institution | 1 |
European Organization for Nuclear Research | Institution | 1 |
DOI | Other Internet | 1 |